Remedy Meds, a consumer-focused virtual care and pharmacy platform, has signed a definitive agreement to acquire Thirty Madison in an all-stock deal valued at slightly over $500 million. Expected to close in Q4 2025, subject to customary approvals, the transaction will integrate Remedy Meds’ weight-loss platform with Thirty Madison’s portfolio, which includes Keeps for men’s hair loss, Nurx for women’s health, and Cove for migraine management.
The merger will establish a multi-brand platform covering men’s, women’s, and metabolic health, supported by nationwide clinician access, integrated pharmacy services, and home delivery. The combined company is projected to generate more than $670 million in annual revenue, with Remedy Meds contributing over $450 million and Thirty Madison adding more than $220 million.
Haris Memon, Founder and CEO of Remedy Meds, stated, “By uniting Thirty Madison’s trusted brands with Remedy Meds’ acquisition engine, retention system, and pharmacy infrastructure, we will expand access, reduce time-to-treatment, and maintain the disciplined growth that defines our company.” Thirty Madison CEO and Co-Founder Demetri Karagas added, “Together, we will make high-quality specialty care more accessible to millions of patients across the conditions we serve.”
Remedy Meds to Combine Leading Brands with Thirty Madison
The merger will bring together top brands—Remedy Meds, Keeps, Nurx, and Cove—leveraging a nationwide clinician and pharmacy network to broaden access to high-demand, digitally scalable treatments.
SUMMIT, N.J., Sept. 3, 2025 /PRNewswire/ — Remedy Meds, LLC, a consumer-focused virtual care and pharmacy platform, announced it has entered into a definitive agreement to acquire Thirty Madison, Inc. The deal will create an expanded, multi-brand platform spanning women’s, men’s, and metabolic health.
Valued just above $500 million, the transaction will be completed through an all-stock agreement. The deal is expected to close in Q4 2025, pending customary closing conditions and regulatory approvals.
Strategic Rationale
- Scaled, multi-brand platform: Combines Remedy Meds (weight loss), Keeps (men’s hair loss), Nurx (women’s health), and Cove (migraine) under one consumer-centric platform with cross-category trust and funnel efficiency.
- Integrated care & pharmacy: Nationwide clinician coverage, insurance coverage, and an integrated pharmacy fulfillment network support same-day video visits, rapid prescription review, tailored treatment plans, and direct-to-door delivery.
- Robust financial performance: Remedy Meds currently generates over $450M in annual revenue with substantial profitability, enabling Thirty Madison’s profitable $220M+ revenue business to leverage the financial strength of a scaled operating platform.
Executive Quotes
“By uniting Thirty Madison’s trusted brands with Remedy Meds’ acquisition engine, retention system, and pharmacy infrastructure, we will expand access, reduce time-to-treatment, and uphold the financial discipline that has fueled our growth,” said Haris Memon, Founder and CEO of Remedy Meds.
“Thirty Madison and Remedy Meds share a commitment to improving the patient healthcare experience. Together, we will make high-quality specialty care more accessible to millions of patients across the conditions we serve. I’m grateful to our teams, clinicians, and partners who made this possible, and I’m excited for what we’ll achieve together in this next chapter as part of Remedy Meds,” said Demetri Karagas, CEO and Co-Founder of Thirty Madison.
About Remedy Meds
Remedy Meds is a consumer health platform that integrates a performance-driven acquisition engine, a clinical retention system, and a nationwide, integrated pharmacy network to provide affordable and convenient treatment for high-demand health conditions.
About Thirty Madison
Thirty Madison delivers end-to-end, high-quality virtual care for patients managing a variety of health conditions. Its brands—Keeps for men’s hair loss, Nurx for women’s health, and Cove for migraine—offer ongoing, personalized care through specialty-level telemedicine. Thirty Madison’s care model focuses on accessibility, affordability, and improving patient outcomes.
Media Contact: media@remedymeds.com
Methuselah Advisors acted as financial advisor, and Weil, Gotshal & Manges LLP served as legal counsel for Remedy Meds. Centerview Partners provided financial advisory services, while Cooley LLP served as legal counsel for Thirty Madison.
